Idexx Laboratories Inc /De (NASDAQ: IDXX)

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and provides services primarily for the companion animal veterinary, livestock, poultry and dairy, and water testing industries. The company also manufactures and sells human medical point-of-care diagnostic products. Idexx creates long-term value by enhancing the health and well-being of pets, people, and livestock through diagnostic and information management solutions.

Idexx generates revenue through the sale of point-of-care veterinary diagnostic products, veterinary reference laboratory diagnostic and consulting services, practice management systems and software, diagnostic imaging systems, health monitoring and biological materials testing products for biomedical research, diagnostic and health-monitoring products for livestock, poultry, and dairy, and water testing products. The company serves veterinarians, livestock and dairy producers, biomedical researchers, water utilities, government laboratories, and human medical facilities through direct sales, independent distributors, and resellers worldwide.

The company operates through the following segments: Companion Animal Group, Water quality products, and Livestock, Poultry and Dairy. An Other operating segment combines human medical diagnostic products and out-licensing arrangements.

• Companion Animal Group: This segment provides diagnostic and information management products and services for the companion animal veterinary industry, including point-of-care diagnostic solutions, outside reference laboratory services, and veterinary software and services. The segment includes the IDEXX VetLab suite of point-of-care chemistry, hematology, immunoassay, electrolyte, urinalysis, cytology/morphology, blood gas, and coagulation analyzers. Key products include the Catalyst One Chemistry analyzer, ProCyte One hematology analyzer, SediVue Dx Analyzer, and IDEXX inVue Dx Cellular Analyzer, which utilize proprietary AI capabilities in image capture systems.

• Water quality products: This segment provides innovative testing solutions and related instrumentation for the detection and quantification of microbiological parameters in water. Core products include the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert for enterococci, Pseudalert for Pseudomonas aeruginosa, and Legiolert for Legionella pneumophila. The segment also offers Filta-Max and Filta-Max xpress for Cryptosporidium and Giardia detection, and Quanti-Tray products for quantitative microbial measurements.

• Livestock, Poultry and Dairy: This segment provides diagnostic tests, services, and instrumentation to manage livestock and poultry health, improve producer efficiency, and measure milk quality and safety. Key products include tests for Bovine Viral Diarrhea Virus, Porcine Reproductive and Respiratory Syndrome, and Transmissible Spongiform Encephalopathies, as well as the Alertys Milk Pregnancy Test and SNAP Beta-Lactam ST and SNAPduo ST Plus for antibiotic residue detection in milk. The segment also offers herd health screening services to veterinarians and producers.

Idexx holds a strong competitive position in its core markets due to the integration of diagnostic technologies, information management systems, and a broad product portfolio. The company competes with Antech Diagnostics, Heska, Zoetis (including Abaxis), Mars, Incorporated brands, Fujifilm Holdings, Arkray, Mindray, BioNote, Neogen Corporation, Charm Sciences, BioChek, Innovative Diagnostics, Thermo Fisher Scientific, Covetrus, Sound-Eklin, and others across its various business areas. Competitive advantages include ease of use, speed, diagnostic accuracy, product quality, breadth of offerings, technological innovation, and effective sales and distribution channels.

Idexx serves veterinarians in companion animal practice, livestock and dairy producers, biomedical research laboratories, water utilities, government and private laboratories testing drinking and recreational water, and human medical facilities. The company also works with pharmaceutical and nutrition partners who use its data for market insights. Specific customer types include veterinary clinics, dairy processors, public health agencies, and research institutions.